Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIOH-1: pritelivir versus foscarnet for acyclovir-resistant mucocutaneous HSV infection in immunocompromised subjects
2020-004940-27Phase 3Active
- Sponsor
- AiCuris
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in mucocutaneous herpes simplex virus infection (HSV) comparing Pritelivir with Foscarnet (2 arms). Started Apr 2021; status: active.
02
Drugs
pritelivirfoscarnet sodium
03
Conditions
mucocutaneous herpes simplex virus infection (HSV)
Beyond the preview
Go deeper on 2020-004940-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004940-27.